Anebulo Pharmaceuticals, Inc. (ANEB) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $11.63M | +275.8% |
| 2024 | $3.09M | -72.5% |
| 2023 | $11.25M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $11.63M | +275.8% |
| 2024 | $3.09M | -72.5% |
| 2023 | $11.25M | — |